Biomarkers of myocardial fibrosis and their genetic regulation in patients with heart failure
Currently, the development of chronic heart failure (CHF) is considered from the perspective of pathological structural remodeling of myocardium and fibrosis. Despite the widespread use of molecular genetic markers in clinical practice, only a small number of them are used to evaluate remodeling pro...
Saved in:
Main Authors: | T. B. Pecherina, A. G. Kutikhin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2020-11-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/3933 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MOLECULAR BIOMARKERS FOR DIAGNOSTICS, RISK STRATIFICATION AND PREDICTION OF CHRONIC HEART FAILURE
by: E. A. Medvedeva, et al.
Published: (2016-08-01) -
Fibrosis biomarkers and global myocardial strain in the diagnosis and prediction of diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction
by: A. V. Osokina, et al.
Published: (2021-07-01) -
BIOMARKERS OF MYOCARDIAL STRESS AND FIBROSIS FOR CLINICAL OUTCOMES ASSESSMENT IN POST MYOCARDIAL INFARCTION HEART FAILURE PATIENTS
by: N V Shilyaeva, et al.
Published: (2018-03-01) -
Relationship between gut microbiota and markers of myocardial fibrosis in with chronic heart failure with preserved ejection fraction
by: A. N. Kaburova, et al.
Published: (2021-07-01) -
Galectin-3 in heart transplant rejection and fibrosis
by: O. P. Shevchenko, et al.
Published: (2019-10-01)